Sipuleucel-T for CRPC
Posted On: 4/9/2015 1:42 PM
The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer: Combining immunotherapy with other treatments may have potent anticancer effects. Understanding the interactions between different mCRPC treatments may offer further potential to improve patient outcomes.
For more information read the entire Article
This article was Co-written by some of the Physicians of Associated Medical Professionals of NY, PLLC: Vladimir Mouraviev MD, Neil Mariados MD, David Albala MD & Christopher Pieczonka MD